文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人感染H7N9后优先诱导产生跨组甲型流感血凝素茎特异性记忆B细胞

Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.

作者信息

Andrews Sarah F, Joyce M Gordon, Chambers Michael J, Gillespie Rebecca A, Kanekiyo Masaru, Leung Kwanyee, Yang Eun Sung, Tsybovsky Yaroslav, Wheatley Adam K, Crank Michelle C, Boyington Jeffrey C, Prabhakaran Madhu S, Narpala Sandeep R, Chen Xuejun, Bailer Robert T, Chen Grace, Coates Emily, Kwong Peter D, Koup Richard A, Mascola John R, Graham Barney S, Ledgerwood Julie E, McDermott Adrian B

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.

出版信息

Sci Immunol. 2017 Jul 14;2(13). doi: 10.1126/sciimmunol.aan2676.


DOI:10.1126/sciimmunol.aan2676
PMID:28783708
Abstract

Antigenic drift and shift of influenza strains underscore the need for broadly protective influenza vaccines. One strategy is to design immunogens that elicit B cell responses against conserved epitopes on the hemagglutinin (HA) stem. To better understand the elicitation of HA stem-targeted B cells to group 1 and group 2 influenza subtypes, we compared the memory B cell response to group 2 H7N9 and group 1 H5N1 vaccines in humans. Upon H7N9 vaccination, almost half of the HA stem-specific response recognized the group 1 and group 2 subtypes, whereas the response to H5N1 was largely group 1-specific. Immunoglobulin repertoire analysis of HA-specific B cells indicated that the H7N9 and H5N1 vaccines induced genetically similar cross-group HA stem-binding B cells, albeit at a much higher frequency upon H7N9 vaccination. These data suggest that a group 2-based stem immunogen could prove more effective than a group 1 immunogen at eliciting broad cross-group protection in humans.

摘要

流感毒株的抗原漂移和转换凸显了研发具有广泛保护作用的流感疫苗的必要性。一种策略是设计能引发针对血凝素(HA)茎部保守表位的B细胞应答的免疫原。为了更好地理解针对1组和2组流感亚型的HA茎部靶向B细胞的激发情况,我们比较了人类对2组H7N9和1组H5N1疫苗的记忆B细胞应答。接种H7N9疫苗后,几乎一半的HA茎部特异性应答可识别1组和2组亚型,而对H5N1的应答主要是1组特异性的。对HA特异性B细胞的免疫球蛋白库分析表明,H7N9和H5N1疫苗诱导出基因上相似的跨组HA茎部结合B细胞,尽管接种H7N9疫苗后其频率要高得多。这些数据表明,基于2组的茎部免疫原在引发人类广泛的跨组保护方面可能比基于1组的免疫原更有效。

相似文献

[1]
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.

Sci Immunol. 2017-7-14

[2]
Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.

Emerg Microbes Infect. 2016-5-25

[3]
Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.

Vaccine. 2014-8-13

[4]
Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.

Vaccine. 2009-8-27

[5]
Platform technology to generate broadly cross-reactive antibodies to α-helical epitopes in hemagglutinin proteins from influenza A viruses.

Biopolymers. 2016-3

[6]
Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.

J Virol. 2015-7

[7]
Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.

Antiviral Res. 2014-9

[8]
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Vaccine. 2013-7-26

[9]
An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.

Emerg Microbes Infect. 2015-4

[10]
Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.

Sci Transl Med. 2012-8-15

引用本文的文献

[1]
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies.

Nat Commun. 2025-8-1

[2]
A single residue change only differing by an atomic group can drive imprinting to influenza.

Res Sq. 2025-7-7

[3]
Public antibodies: convergent signatures in human humoral immunity against pathogens.

mBio. 2025-5-14

[4]
Distinct binding modes drive the broad neutralization profile of two persistent influenza hemagglutinin stem-specific antibody lineages.

Structure. 2025-5-1

[5]
Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later.

Immunity. 2025-3-11

[6]
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.

Proc Natl Acad Sci U S A. 2025-2-18

[7]
Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of V3 and V3 genes.

Nat Commun. 2025-2-2

[8]
Human naïve B cells recognize prepandemic influenza virus hemagglutinins.

Sci Immunol. 2025-1-24

[9]
Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human Antibodies.

bioRxiv. 2024-12-3

[10]
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem.

Cell Rep. 2024-12-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索